Event details
We sat down with Ben Osborn, MD of Pfizer UK, to discuss how he lives his purpose within one of the largest pharmaceutical companies in the world.
As scrutiny on how businesses behave increases, and leaders have to navigate their own values, the corporate values and the values of their stakeholders, it is more critical than ever to understand what we stand for.
Presenters
Ben Osborn
President International Commercial Office
Pfizer
Transform don’t tinker!
My passion is developing innovative approaches to healthcare challenges, utilising novel technologies and data to support patient outcomes and building an engaging culture, delivering value for patients, colleagues and shareholders.
Experienced pharmaceutical leader having worked in multiple senior leadership and general management roles both in the U.K. and across Europe, Japan, China and Emerging markets. Strong experience across multiple disease areas; Vaccines, Oncology, Obesity and Speciality medicines in particular. Proven ability to manage and grow significant $multi B P&Ls and lead cross functional teams across the globe.
Successfully delivered across country and International roles to bring new medicines and vaccines to launch from early clinical trial development, alongside M&A. Deep general management and marketing experience having led commercial organizations to build industry leading portfolios in multiple disease areas and transform outcomes driven by science, data and technology.
Pioneering transformation and new commercial models for an era driven by data, AI in a rapidly changing healthcare environment.
My passion is developing innovative approaches to healthcare challenges, utilising novel technologies and data to support patient outcomes and building an engaging culture, delivering value for patients, colleagues and shareholders.
Experienced pharmaceutical leader having worked in multiple senior leadership and general management roles both in the U.K. and across Europe, Japan, China and Emerging markets. Strong experience across multiple disease areas; Vaccines, Oncology, Obesity and Speciality medicines in particular. Proven ability to manage and grow significant $multi B P&Ls and lead cross functional teams across the globe.
Successfully delivered across country and International roles to bring new medicines and vaccines to launch from early clinical trial development, alongside M&A. Deep general management and marketing experience having led commercial organizations to build industry leading portfolios in multiple disease areas and transform outcomes driven by science, data and technology.
Pioneering transformation and new commercial models for an era driven by data, AI in a rapidly changing healthcare environment.